Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain

被引:97
作者
Bashkatova, V
Alam, M
Vanin, A
Schmidt, WJ
机构
[1] Univ Tubingen, Zool Inst Neuropharmacol, D-72076 Tubingen, Germany
[2] Russian Acad Med Sci, Inst Pharmacol, Moscow 125315, Russia
基金
俄罗斯基础研究基金会;
关键词
rotenone; neurotoxicity; nitric oxide (NO); thiobarbituric acid (TBARS);
D O I
10.1016/j.expneurol.2003.12.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The complex I inhibitor rotenone is a neurotoxin that has been proposed to induce Parkinson-like degeneration. As the mechanisms of rotenone toxicity are not fully understood, the present study addresses the question of whether rotenone induces NO production and lipid peroxidation-like products, that is, thiobarbituric acid reactive substances (TBARS). Rotenone at a dose of 1.5 mg kg(-1) ip was administered to rats daily for 10, 20; 30, and 60 days, and NO and TBARS were measured in the frontal cortex and in the striatum. On the 1st and 10th day, there were no increases in NO and TBARS levels, after 20 days, the NO and TBARS levels were increased in the striatum. After 30 and 60 days, NO and TBARS levels were increased in striatum and frontal cortex. Behaviorally, on days 30 and 60, the rats exhibited akinesia and rigidity in the catalepsy test. These results show that chronic administration of rotenone over a long period is capable of increasing NO and TBARS in the cortex and striatum and mimics Parkinson's disease (PD)-like behavioral symptoms that are akinesia and rigidity in rats. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 31 条
[1]   Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats [J].
Alam, M ;
Schmidt, WJ .
BEHAVIOURAL BRAIN RESEARCH, 2002, 136 (01) :317-324
[2]   Influence of NOS inhibitors on changes in ACH release and NO level in the brain elicited by amphetamine neurotoxicity [J].
Bashkatova, V ;
Kraus, M ;
Prast, H ;
Vanin, A ;
Rayevsky, K ;
Philippu, A .
NEUROREPORT, 1999, 10 (15) :3155-3158
[3]   Experimental models of Parkinson's disease [J].
Beal, MF .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) :325-332
[4]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[5]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[6]   QUINOLINIC ACID LESIONS OF RAT STRIATUM ABOLISH D1-DOPAMINE AND D2-DOPAMINE RECEPTOR-MEDIATED CATALEPSY [J].
CALDERON, SF ;
SANBERG, PR ;
NORMAN, AB .
BRAIN RESEARCH, 1988, 450 (1-2) :403-407
[7]   Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide [J].
Cammack, R ;
Shergill, JK ;
Inalsingh, VA ;
Hughes, MN .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1998, 54 (14) :2393-2402
[8]  
Castagnoli K., 1999, Neurobiology (Budapest), V7, P135
[9]   Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide [J].
Daveu, C ;
Servy, C ;
Dendane, M ;
Marin, P ;
Ducrocq, C .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1997, 1 (03) :234-243
[10]   Where does Parkinson disease pathology begin in the brain? [J].
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Bohl, JRE ;
Braak, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05) :413-426